Nutrien Ltd

Discover why Morgan Stanley and UBS are raising Nutrien’s targets, what their neutral stance means, and how the company’s tech‑driven, sustainable strategy could fuel future growth in a volatile fertilizer market.

Explore why Nutrien Ltd. is gaining analyst upgrades – potash dominance, fast‑growing sulfur‑based micronutrients, precision agriculture tech, and a solid valuation profile that could outperform peers.

See how Nutrien’s modest share‑price rise reflects steady valuation and solid earnings‑to‑price, underscoring its resilient, diversified fertilizer business.

Discover how Nutrien’s portfolio simplification and growth‑focused strategy boosts value, reduces commodity risk, and positions the company for tech‑driven, sustainable farming success.

Explore Nutrien’s 2025 market outlook: solid earnings, regulatory pressures, and growth opportunities in sustainable fertilizers and emerging markets.

Explore Nutrien’s resilient 2025 outlook: stable EPS, green upgrades, and AI‑driven ag tech—how the U.S. sanctions lift and global potash dynamics shape its future.

Discover why Nutrien Ltd. stays investor‑favored: solid earnings, sector‑aligned P/E, and steady growth in potash, nitrogen, and phosphate markets.

Analyze Nutrien’s 2025 divestiture of its Argentine stake and the resulting option‑market spike, uncovering strategic shifts, market dynamics, and investor implications.

NUTRIEN sells its 50% stake in Profertil for C$3.2 billion, cutting non‑core assets and boosting cash flow while keeping a 5% residual interest that preserves strategic ties in Argentina’s high‑growth nitrogen market.

Explore Nutrien’s $1 Billion Longview export terminal that boosts U.S. potash shipping, diversifies logistics, and meets global fertilizer demand.